We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Common Drug Shows Potential as Alzheimer's Cure

A research project has shown that an experimental model of Alzheimer’s disease can be successfully treated with a commonly used anti-inflammatory drug.
News

Characterizing the Mouse Gut Microbiome

Study establishes the first public collection of bacteria from the intestine of mice.
News

Schizophrenia, Autism Share Genetic Causes

Monkey brain developmental atlas pinpoints when, where genes activate.
News

Tobacco Hornworm Genome Sequenced

A Kansas State University-led international team has sequenced the genome of the tobacco hornworm — a caterpillar species used in many research laboratories for studies of insect biology.
News

Novel Therapeutic Approach for Blood Disorders

Gene editing of human blood-forming stem cells mimics a benign genetic condition that helps to overcome sickle cell disease and other blood disorders.
News

Understanding Tumor Evolution

Study provides insight into tumor evolution; may point to improved diagnosis and treatment.
News

Esteve Gains Sample Management Efficiencies Using Titian’s Software

The Mosaic software has been extended to support the whole of sample management research at Esteve’s R&D site.
News

How Parkinson’s Disease Alters Brain Activity Over Time

The NIH study provides a new tool for testing experimental medications aimed at alleviating symptoms and slowing the rate at which the diseases damage the brain.
News

PARP Proteins Explore Therapeutic Targets in Cancer

Researchers at UTSW have identified a previously unknown role of a certain class of proteins that opens the door to explore therapeutic targets in cancer and other disease.
News

How Parkinson's disease alters brain activity over time

Neuroscientists peered into the brains of patients with Parkinson's disease and two similar conditions to see how their neural responses changed over time. The study, funded by the National Institutes of Health's (NIH's, USA) Parkinson's Disease Biomarkers Program and published in Neurology, may provide a new tool for testing experimental medications aimed at alleviating symptoms and slowing the rate at which the diseases damage the brain.
Advertisement